Advertisement

Cancer Chemotherapy and Pharmacology

, Volume 50, Issue 5, pp 367–372 | Cite as

Establishment and characterization of a mouse FM3A cell mutant resistant to topoisomerase II-inhibitor NC-190

  • Kazunori Samata
  • Takehiro Yamagishi
  • Tomoko Ichihara
  • Kayoko Nanaumi
  • Tomotake Ikeda
  • Hisao Ikeya
  • Aiko Kuraishi
  • Shiro Nakaike
  • Keiko Kashiwagi
  • Kazuei Igarashi
Original Article

Abstract.

We established an NC-190-resistant cell line, FM/NC-R, from the murine mammary carcinoma cell line FM3A and examined some of its characteristics. FM/NC-R cells were prepared by mutagen treatment followed by exposure to NC-190 in the culture medium. FM/NC-R cells were 76.5 times more resistant against NC-190 than FM3A cells as measured by their growth in vitro. FM/NC-R cells also showed cross-resistance to etoposide with NC-190. Neither NC-190 nor etoposide increased the lifespan of FM/NC-R-bearing mice at doses that prolonged the lifespan of FM3A-bearing mice more than four times. This resistance was not due to the change in the concentration of NC-190 in the cells, and there was no change in the expression of P-glycoprotein, a drug efflux pump in the cells. NC-190 and etoposide are inhibitors of DNA topoisomerase II, but there was no difference in cellular content of DNA topoisomerase II between the two cell lines as determined by Western blot analysis. The stabilization of DNA-DNA topoisomerase II cleavable complexes induced by NC-190 was lost in FM/NC-R cells. It was found that Gly881, which is located in the ATP binding site, was replaced by Arg in topoisomerase IIα of FM/NC-R cells. These results indicate that the NC-190-resistant cell line FM/NC-R contains a mutated DNA topoisomerase IIα.

NC-190-resistant FM/NC-R cells DNA topoisomerase II inhibitor Mutated DNA topoisomerase IIα 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag 2002

Authors and Affiliations

  • Kazunori Samata
    • 1
  • Takehiro Yamagishi
    • 1
  • Tomoko Ichihara
    • 1
  • Kayoko Nanaumi
    • 1
  • Tomotake Ikeda
    • 1
  • Hisao Ikeya
    • 1
  • Aiko Kuraishi
    • 1
  • Shiro Nakaike
    • 1
  • Keiko Kashiwagi
    • 2
  • Kazuei Igarashi
    • 2
  1. 1.Medicinal Research Laboratories, Taisho Pharmaceutical Co. Ltd., 1-403 Yoshino-cho, Saitama 330-8530, Japan
  2. 2.Graduate School of Pharmaceutical Sciences, Chiba University, 1-33 Yayoi-cho, Inage-ku, Chiba 263-8522, Japan

Personalised recommendations